首页> 外文期刊>Expert opinion on drug metabolism & toxicology >Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis
【24h】

Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis

机译:遗传和后天因素影响骨质疏松症药物治疗的有效性和毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Osteoporosis is a highly prevalent skeletal disorder characterized by compromised bone strength, usually related to decreased bone mass and microstructural alterations of bone tissue, predisposing a person to an increased risk of fracture. As other prevalent disorders, osteoporosis is the result of a complex interplay of genetic and acquired factors.
机译:简介:骨质疏松症是一种高度流行的骨骼疾病,其特征是骨骼强度受损,通常与骨量减少和骨组织的微结构改变有关,使人容易发生骨折。与其他普遍的疾病一样,骨质疏松症是遗传因素和后天因素复杂相互作用的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号